Networks

A Twist of Fate-ATS is a nonprofit and is the only international patient group for ATS. “Our mission is a world wide initiative to find a cure for arterial tortuosity syndrome, by supporting research, education, awareness, and families.” We have been able to assist the older gentleman with his primary...
Established in the United States in 1993, the A-T Children’s Project is a 501c3 nonprofit organization that raises funds to support and coordinate biomedical research projects, scientific conferences and a clinical center aimed at finding life-improving therapies and a cure for ataxia-telangiectasia (A-T). A-T is a rare, genetic disease that...
Ablynx, a biopharmaceutical company with headquarters in Ghent, Belgium, is engaged in the discovery and development of Nanobodies® to treat a range of serious human diseases. Nanobodies® are a novel class of antibody-derived therapeutic proteins. Because of their small size, unique structure and extreme stability, Nanobodies® combine the advantages of...
The Academy of Doctors of Audiology (ADA) was founded by nine practitioners in 1977, as the Academy of Dispensing Audiologists, to foster and support the professional dispensing of hearing aids by qualified audiologists in rehabilitative practices. Later, in 1988, the ADA developed the concept of the Doctor of Audiology (Au.D.)...
Acanthosis nigricans (ak-an-THOE-sis NIE-grih-kuns) is a skin condition characterized by areas of dark, velvety discoloration in body folds and creases. The affected skin can become thickened and may smell bad. Most often, acanthosis nigricans affects your armpits, groin and nec
The Accelerated Cure Project for Multiple Sclerosis (ACP) is a patient-founded national non-profit organization dedicated to accelerating advances toward a cure for MS. ACP believes that research is the only way to greatly improve the outlook for people with MS. The organization promotes scientific collaboration and accelerates research by rapidly...
Accera, a privately held biotechnology company, discovers and develops breakthroughs in treating central nervous systems disorders. Accera’s new and novel therapeutic approaches positively impact patients with neurodegenerative disorders, who are in need of effective, well-tolerated treatments, and their families. Through its proprietary scientific platform, Accera is developing therapies that address...
Welcome to the HealthShare International Support Network’s community for individuals affected by ‘Achalasia.’ Members are also invited to check out the HealthShare International’s Support Community Center. Our community center is a gathering place for members interested in meeting new friends and sharing disease information and support with others from over...
Join the HealthShare International Support Network’s support community for ‘Achondroplastic Dwarfism’ and begin making friends, sharing information and support with others affected by this disorder.  
Congenital achromatopsia is a rare hereditary vision disorder which affects 1 person in 33,000 in the U. S. The incidence varies in different parts of the world.